scholarly journals Autologous bone marrow derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single‐center, open‐label TRITON study

2021 ◽  
Author(s):  
Marlies E.J. Reinders ◽  
Koen E. Groeneweg ◽  
Sanne H. Hendriks ◽  
Jonna R. Bank ◽  
Geertje J. Dreyer ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Cell Therapy ◽  
Mesenchymal Stromal Cell ◽  
Stromal Cell ◽  
Autologous Bone Marrow ◽  
Single Center ◽  
Open Label ◽  
Autologous Bone

scholarly journals Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities

Cytotherapy ◽  
2020 ◽  
Vol 22 (6) ◽  
pp. 313-321
Author(s):  
Sara Azhari Mohamed ◽  
Linda Howard ◽  
Veronica McInerney ◽  
Amjad Hayat ◽  
Janusz Krawczyk ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Cell Therapy ◽  
Critical Limb Ischemia ◽  
Mesenchymal Stromal Cell ◽  
Stromal Cell ◽  
Autologous Bone Marrow ◽  
Limb Ischemia ◽  
Autologous Bone

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

Gut ◽  
2010 ◽  
Vol 59 (12) ◽  
pp. 1662-1669 ◽  
Author(s):  
Marjolijn Duijvestein ◽  
Anne Christine W Vos ◽  
Helene Roelofs ◽  
Manon E Wildenberg ◽  
Barbara B Wendrich ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Phase I ◽  
Mesenchymal Stromal Cell ◽  
Phase I Study ◽  
Stromal Cell ◽  
Autologous Bone Marrow ◽  
Autologous Bone
Sign in / Sign up

Export Citation Format

Share Document